https://nl.marketscreener.com/koers/aandeel/SERES-THERAPEUTICS-INC-22619573/nieuws/Seres-Therapeutics-meldt-SER-155-Fase-1b-Cohort-1-resultaten-die-een-succesvolle-enting-van-geneesmi-43799693/?utm_source=telegram&utm_medium=social&utm_campaign=share